Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid gland.
Journal
The Lancet. Oncology
ISSN: 1474-5488
Titre abrégé: Lancet Oncol
Pays: England
ID NLM: 100957246
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
03
04
2020
revised:
26
05
2020
accepted:
05
06
2020
entrez:
5
11
2020
pubmed:
6
11
2020
medline:
31
12
2020
Statut:
ppublish
Résumé
Most primary thyroid tumours are of epithelial origin. Primary thyroid mesenchymal tumours are rare but are being increasingly detected. A vast majority of thyroid mesenchymal tumours occur between the fourth and seventh decades of life, presenting as progressively enlarging thyroid nodules that often yield non-diagnostic results or spindle cells on fine needle aspiration biopsy. Surgery is the preferred mode of treatment, with adjuvant chemoradiotherapy used for malignant thyroid mesenchymal tumours. Benign thyroid mesenchymal tumours have excellent prognosis, whereas the outcome of malignant thyroid mesenchymal tumours is variable. Each thyroid mesenchymal tumour is characterised by its unique histopathology and immunohistochemistry. Because of the rarity and aggressive nature of malignant thyroid mesenchymal tumours, a multidisciplinary team-based approach should ideally be used in the management of these tumours. Comprehensive guidelines on the management of thyroid mesenchymal tumours are currently lacking. In this Review, we provide a detailed description of thyroid mesenchymal tumours, their clinical characteristics and tumour behaviour, and provide recommendations for the optimal management of these tumours.
Identifiants
pubmed: 33152312
pii: S1470-2045(20)30332-6
doi: 10.1016/S1470-2045(20)30332-6
pmc: PMC9597611
mid: NIHMS1834544
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e528-e537Subventions
Organisme : Intramural NIH HHS
ID : Z01 DK047053
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DK047053
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
Oral Oncol. 2018 Jul;82:48-52
pubmed: 29909901
Eur Thyroid J. 2018 Oct;7(5):262-266
pubmed: 30374430
Anticancer Res. 2015 Oct;35(10):5185-91
pubmed: 26408676
Diagn Cytopathol. 2015 May;43(5):416-20
pubmed: 25614185
G Chir. 2018 Jan-Feb;39(1):51-56
pubmed: 29549682
Hum Pathol. 2012 Dec;43(12):2371-5
pubmed: 23079201
Rare Tumors. 2017 Sep 15;9(2):6834
pubmed: 28975018
Acta Cytol. 2007 May-Jun;51(3):421-3
pubmed: 17536546
Mod Pathol. 2014 Jan;27 Suppl 1:S30-8
pubmed: 24384851
Cell. 2014 Oct 23;159(3):676-90
pubmed: 25417114
J Ultrasound. 2018 Jun;21(2):165-168
pubmed: 29374396
Pol J Pathol. 2018;69(1):53-61
pubmed: 29895127
Biochim Biophys Acta. 2015 Aug;1856(1):121-9
pubmed: 26050962
Thyroid Res. 2018 Jul 31;11:11
pubmed: 30083234
J Am Coll Radiol. 2015 Dec;12(12 Pt A):1272-9
pubmed: 26419308
Otolaryngol Head Neck Surg. 2000 Jan;122(1):143-4
pubmed: 10629502
Diagn Cytopathol. 2008 Aug;36(8):589-94
pubmed: 18618703
J Clin Endocrinol Metab. 2011 Jun;96(6):1623-4
pubmed: 21602455
Best Pract Res Clin Endocrinol Metab. 2010 Jun;24(3):415-24
pubmed: 20833333
Thyroid. 2010 Jun;20(6):583-6
pubmed: 20553194
Clin Imaging. 2014 Nov-Dec;38(6):826-30
pubmed: 25103962
Cancer Rep Rev. 2017;1(2):
pubmed: 28626837
Head Neck Pathol. 2020 Sep;14(3):701-706
pubmed: 31782115
Thyroid. 2012 Nov;22(11):1104-39
pubmed: 23130564
Exp Mol Pathol. 2015 Feb;98(1):99-101
pubmed: 25562414
Endocr Pract. 2006 Jan-Feb;12(1):63-102
pubmed: 16596732
Front Endocrinol (Lausanne). 2017 Oct 27;8:257
pubmed: 29163353
Clin Cancer Res. 2015 Sep 1;21(17):3888-95
pubmed: 25873086
Virchows Arch. 2004 Sep;445(3):315-9
pubmed: 15243738
J Clin Endocrinol Metab. 2011 Sep;96(9):2779-85
pubmed: 21752889
Am J Clin Pathol. 2015 Aug;144(2):322-8
pubmed: 26185318
N Engl J Med. 2003 Feb 20;348(8):694-701
pubmed: 12594313
Anticancer Res. 2018 Sep;38(9):5275-5282
pubmed: 30194178
Cell. 2017 Nov 2;171(4):950-965.e28
pubmed: 29100075
Am J Surg Pathol. 2015 Sep;39(9):1267-74
pubmed: 26034869
Medicine (Baltimore). 2017 Dec;96(49):e8651
pubmed: 29245224
Eur J Surg Oncol. 2009 Jun;35(6):649-53
pubmed: 18922667
Endocr Pathol. 1996 Winter;7(4):309-318
pubmed: 12114802
J Microsc Ultrastruct. 2019 Nov 08;8(1):1-6
pubmed: 32166057
Endocr Relat Cancer. 2015 Apr;22(2):191-204
pubmed: 25595276
Laryngoscope. 2013 Aug;123(8):2072-6
pubmed: 23625578
Clin Nucl Med. 2015 Mar;40(3):e208-10
pubmed: 25140545
Hum Pathol. 2014 May;45(5):1084-91
pubmed: 24746215
Surgery. 1997 Sep;122(3):548-52
pubmed: 9308612
Am J Surg Pathol. 2014 Jan;38(1):13-22
pubmed: 24145643
Head Neck Pathol. 2019 Dec;13(4):597-605
pubmed: 30758754
Int J Pediatr Otorhinolaryngol. 2005 Feb;69(2):267-70
pubmed: 15656963
N Engl J Med. 2015 Dec 10;373(24):2347-56
pubmed: 26650154
Acta Chir Belg. 2008 Nov-Dec;108(6):702-7
pubmed: 19241922
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):401-5
pubmed: 15380572
Can Med Assoc J. 1966 Dec 10;95(24):1254-9
pubmed: 5954492
Eur Thyroid J. 2018 Mar;7(2):102-108
pubmed: 29594062
J Cancer Res Ther. 2020 Dec;16(Supplement):S11-S21
pubmed: 33380646
Vojnosanit Pregl. 2014 Sep;71(9):875-8
pubmed: 25282787
Int J Endocrinol. 2014;2014:790834
pubmed: 25214840
Mol Clin Oncol. 2019 Sep;11(3):219-224
pubmed: 31384458
World J Clin Cases. 2019 Feb 26;7(4):473-481
pubmed: 30842958
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Thyroid. 2015 Jun;25(6):567-610
pubmed: 25810047
Am J Clin Pathol. 2006 Jun;125 Suppl:S95-123
pubmed: 16830961
Clin Nucl Med. 2010 Jul;35(7):517-20
pubmed: 20548146
J Laryngol Otol. 1984 Oct;98(10):1063-6
pubmed: 6491491
Thyroid. 2012 Jan;22(1):88-93
pubmed: 22168229
Arch Otolaryngol Head Neck Surg. 1989 Aug;115(8):991-3
pubmed: 2751862
Semin Diagn Pathol. 2019 Mar;36(2):85-94
pubmed: 30857767
Genes Chromosomes Cancer. 2012 Feb;51(2):127-39
pubmed: 22034177